FDA
-
-
-
-
-
-
-
The Race for the Global Radiotherapy Cancer Market; Actinium Pharmaceuticals' (ATNM) Big Bet
-
-
-
-
-
-
-
FDA approves NOVN's Leqvio for first-line cholesterol treatment
-
-
-
-
-
-
-
GeminiBio Appoints Mike Stella to Board
-
-
-
-
-
-
-
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
-
-
-
-
-
-
-
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo
-
-
-
-
-
-
-
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise
-
-
-
-
-
-
-
Midday movers: Estee Lauder, Eli Lilly and more
-
323,085 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

